<span style="color:#34495E;font-family:"font-size:14px;background-color:#FFFFFF;">LXS-196 is a potent and orally active protein kinase C inhibitor for the treatment of uveal melanoma.
For research use only. We do not sell to patients.
Name | LXS-196 |
---|---|
Iupac Chemical Name | 3-amino-N-(3-(4-amino-4-methylpiperidin-1-yl)pyridin-2-yl)-6-(3-(trifluoromethyl)pyridin-2-yl)pyrazine-2-carboxamide |
Synonyms | LXS-196; LXS 196; LXS196. |
Molecular Formula | C22H23F3N8O |
Molecular Weight | 472.4762 |
Smile | NC=1C(=NC(=CN1)C1=NC=CC=C1C(F)(F)F)C(=O)NC1=NC=CC=C1N1CCC(CC1)(C)N |
InChiKey | XXJXHXJWQSCNPX-UHFFFAOYSA-N |
InChi | InChI=1S/C22H23F3N8O/c1-21(27)6-10-33(11-7-21)15-5-3-9-29-19(15)32-20(34)17-18(26)30-12-14(31-17)16-13(22(23,24)25)4-2-8-28-16/h2-5,8-9,12H,6-7,10-11,27H2,1H3,(H2,26,30)(H,29,32,34) |
CAS Number | 1874276-76-2 |
Related CAS |
Packaging | Price | Availability | Purity | Shipping Time |
---|---|---|---|---|
Bulk | Enquiry | Enquiry | Enquiry |
Formulation | off-white solid |
---|---|
Purity | 98.0% |
Storage | -20 ºC for 3 years |
Solubility | Soluble in DMSO |
Handling | |
Shipping Condition | Shipped under ambient temperature |
HS Code |
Targets | |
---|---|
Mechanism | |
Cell study | |
Animal study | |
Clinical study |